Related Experiment Video
Updated: May 1, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
Published on: April 28, 2022
Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from
Masaaki Nakayama1, Hiroyuki Terawaki
1Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan.
Abstract:
Peritoneal dialysis is established as a first-line standard renal replacement therapy for end-stage renal disease. However, the development of encapsulating peritoneal sclerosis has been a critical complication among long-term peritoneal dialysis patients. During the past decade, multidisciplinary approaches have been used to suppress encapsulating peritoneal sclerosis. The present article reviews the historical and present status of encapsulating peritoneal sclerosis in Japan.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care

